ANDY SASSINE Insider Trading $NRBO NeuroBo Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANDY SASSINE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANDY SASSINE. ANDY SASSINE is in ICAD INC ($ICAD) and Director in ICAD INC ($ICAD) and in MYnd Analytics, Inc. ($CNSO) and Director in MYnd Analytics, Inc. ($CNSO) and Director in Gemphire Therapeutics Inc. ($GEMP) and Director in EXICURE, INC. ($XCUR) and Chief Financial Officer in Arcturus Therapeutics Holdings Inc. ($ARCT).
ANDY SASSINE in NeuroBo Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ANDY SASSINE: Director
Holdings: 151,264 shares
Current Value: $1,621,550
Latest Transaction: Jul 26 2019
$NRBO Market Capitalization: $97.34M
$NRBO Previous Close: $10.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ANDY SASSINE in NeuroBo Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARCT, MYND, XCUR, ICAD, NRBO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 26 2019 | GEMP | Gemphire Therapeut ... | SASSINE ANDY | Director | Grant | A | 0.00 | 15,000 | 0 | 151,264 | 136.3 K to 151.3 K (+11.01 %) |
| Jan 30 2018 | GEMP | Gemphire Therapeut ... | SASSINE ANDY | Director | Option Exercise | A | 10.44 | 10,800 | 112,752 | 10,800 | |
| Mar 14 2017 | GEMP | Gemphire Therapeut ... | SASSINE ANDY | Director | Option Exercise | P | 10.40 | 15,840 | 164,736 | 15,840 | |
| Mar 14 2017 | GEMP | Gemphire Therapeut ... | SASSINE ANDY | Director | Buy | P | 9.47 | 21,119 | 199,997 | 136,264 | 115.1 K to 136.3 K (+18.34 %) |
| Aug 12 2016 | GEMP | Gemphire Therapeut ... | SASSINE ANDY | Director | Option Exercise | C | 0.00 | 75,080 | 0 | 0 | |
| Aug 12 2016 | GEMP | Gemphire Therapeut ... | SASSINE ANDY | Director | Buy | C | 6.71 | 31,853 | 213,603 | 115,145 | 83.3 K to 115.1 K (+38.24 %) |
| Aug 12 2016 | GEMP | Gemphire Therapeut ... | SASSINE ANDY | Director | Buy | J | 6.71 | 8,212 | 55,069 | 83,292 | 75.1 K to 83.3 K (+10.94 %) |
| Aug 12 2016 | GEMP | Gemphire Therapeut ... | SASSINE ANDY | Director | Buy | C | 0.00 | 75,080 | 0 | 75,080 | 0 to 75.1 K |
| Aug 08 2016 | GEMP | Gemphire Therapeut ... | SASSINE ANDY | Director | Option Exercise | A | 10.00 | 60,000 | 600,000 | 60,000 |
Page: 1